Discover why Zacks rates QEP as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore QEPC's strong cash flow and...

Discover why Zacks rates QEP as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore QEPC's strong cash flow and...

Discover why Zacks, the first on Wall Street to initiate coverage, rates IVDA as "Neutral." Explore how Iveda Solutions is extending its cash runway...

Discover why Zacks, the first on Wall Street to initiate coverage, rates IVDA as "Neutral." Explore how Iveda Solutions is extending its cash runway...

Discover why Zacks, the first on Wall Street to initiate coverage, rates ZEO as "Neutral." Explore how ZEO is driving margin expansion, entering an...

Discover why Zacks, the first on Wall Street to initiate coverage, rates ZEO as "Neutral." Explore how ZEO is driving margin expansion, entering an...

Discover why Zacks initiated coverage on LVLU with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how...

Discover why Zacks initiated coverage on LVLU with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how...

PLTR trades 34.8% below its high despite surging revenue, rapid AI expansion and guidance calling for 61% growth and strong cash flow in 2026.

KUALA LUMPUR: RHB Research has initiated coverage on LAC Med Bhd with a “Buy” recommendation, citing expectations that the company will benefit...